These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 19184435)

  • 1. Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics.
    Kaneda MM; Caruthers S; Lanza GM; Wickline SA
    Ann Biomed Eng; 2009 Oct; 37(10):1922-33. PubMed ID: 19184435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics.
    Tran TD; Caruthers SD; Hughes M; Marsh JN; Cyrus T; Winter PM; Neubauer AM; Wickline SA; Lanza GM
    Int J Nanomedicine; 2007; 2(4):515-26. PubMed ID: 18203420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging nanomedicine opportunities with perfluorocarbon nanoparticles.
    Winter PM; Cai K; Caruthers SD; Wickline SA; Lanza GM
    Expert Rev Med Devices; 2007 Mar; 4(2):137-45. PubMed ID: 17359221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymeric perfluorocarbon nanoemulsions are ultrasound-activated wireless drug infusion catheters.
    Zhong Q; Yoon BC; Aryal M; Wang JB; Ilovitsh T; Baikoghli MA; Hosseini-Nassab N; Karthik A; Cheng RH; Ferrara KW; Airan RD
    Biomaterials; 2019 Jun; 206():73-86. PubMed ID: 30953907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational manufacturing of functionalized, long-term stable perfluorocarbon-nanoemulsions for site-specific
    Krämer W; Grapentin C; Bouvain P; Temme S; Flögel U; Schubert R
    Eur J Pharm Biopharm; 2019 Sep; 142():114-122. PubMed ID: 31220572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadolinium-modulated 19F signals from perfluorocarbon nanoparticles as a new strategy for molecular imaging.
    Neubauer AM; Myerson J; Caruthers SD; Hockett FD; Winter PM; Chen J; Gaffney PJ; Robertson JD; Lanza GM; Wickline SA
    Magn Reson Med; 2008 Nov; 60(5):1066-72. PubMed ID: 18956457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-angiogenic perfluorocarbon nanoparticles for diagnosis and treatment of atherosclerosis.
    Caruthers SD; Cyrus T; Winter PM; Wickline SA; Lanza GM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):311-23. PubMed ID: 20049799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine: perspective and promises with ligand-directed molecular imaging.
    Pan D; Lanza GM; Wickline SA; Caruthers SD
    Eur J Radiol; 2009 May; 70(2):274-85. PubMed ID: 19268515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions.
    Rapoport N; Nam KH; Gupta R; Gao Z; Mohan P; Payne A; Todd N; Liu X; Kim T; Shea J; Scaife C; Parker DL; Jeong EK; Kennedy AM
    J Control Release; 2011 Jul; 153(1):4-15. PubMed ID: 21277919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of targeted perfluorocarbon nanoparticle binding using 19F diffusion weighted MR spectroscopy.
    Waters EA; Chen J; Yang X; Zhang H; Neumann R; Santeford A; Arbeit J; Lanza GM; Wickline SA
    Magn Reson Med; 2008 Nov; 60(5):1232-6. PubMed ID: 18956417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted contrast agents for magnetic resonance imaging and ultrasound.
    Morawski AM; Lanza GA; Wickline SA
    Curr Opin Biotechnol; 2005 Feb; 16(1):89-92. PubMed ID: 15722020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoplatforms for targeted molecular imaging in living subjects.
    Cai W; Chen X
    Small; 2007 Nov; 3(11):1840-54. PubMed ID: 17943716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular imaging with targeted perfluorocarbon nanoparticles: quantification of the concentration dependence of contrast enhancement for binding to sparse cellular epitopes.
    Marsh JN; Partlow KC; Abendschein DR; Scott MJ; Lanza GM; Wickline SA
    Ultrasound Med Biol; 2007 Jun; 33(6):950-8. PubMed ID: 17434667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer.
    Rapoport N
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(5):492-510. PubMed ID: 22730185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of
    Bouvain P; Flocke V; Krämer W; Schubert R; Schrader J; Flögel U; Temme S
    MAGMA; 2019 Feb; 32(1):133-145. PubMed ID: 30498884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid Cancer Detection by Ultrasound Molecular Imaging with SHP2-Targeted Perfluorocarbon Nanoparticles.
    Hu Z; Yang B; Li T; Li J
    Contrast Media Mol Imaging; 2018; 2018():8710862. PubMed ID: 29706844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions.
    Lanza GM; Winter PM; Caruthers SD; Hughes MS; Hu G; Schmieder AH; Wickline SA
    Angiogenesis; 2010 Jun; 13(2):189-202. PubMed ID: 20411320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative (1)H MRI, (19)F MRI, and (19)F MRS of cell-internalized perfluorocarbon paramagnetic nanoparticles.
    Kok MB; de Vries A; Abdurrachim D; Prompers JJ; Grüll H; Nicolay K; Strijkers GJ
    Contrast Media Mol Imaging; 2011; 6(1):19-27. PubMed ID: 20648660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoemulsion contrast agents with sub-picomolar sensitivity for xenon NMR.
    Stevens TK; Ramirez RM; Pines A
    J Am Chem Soc; 2013 Jul; 135(26):9576-9. PubMed ID: 23742228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfluorocarbon nanoparticles for physiological and molecular imaging and therapy.
    Chen J; Pan H; Lanza GM; Wickline SA
    Adv Chronic Kidney Dis; 2013 Nov; 20(6):466-78. PubMed ID: 24206599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.